Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
The Journal of Headache and Pain
|
April 4, 2025
Correction: Combining treatments for migraine prophylaxis: the state‑of‑the‑art
Lanfranco Pellesi, David Garcia-Azorin, Eloisa Rubio-Beltrán, et al.
The Journal of Headache and Pain
|
October 9, 2023
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention - part 3: topiramate
Bianca Raffaelli, David García-Azorín, Deirdre M Boucherie, et al.
JAMA Network Open
|
June 17, 2025
Erenumab for Chronic Cluster Headache: A Randomized Clinical Trial
Jasper Mecklenburg, Charly Gaul, Mira Fitzek, et al.
The Journal of Headache and Pain
|
March 2, 2026
Hallmarks of headache disorders: part 5 - secondary headaches
David García-Azorín, Alba Perez-de-la-Parte, Claudio Tana, et al.
The Journal of Headache and Pain
|
October 12, 2022
European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
Simona Sacco, Christian Lampl, Faisal Mohammad Amin, et al.
The Journal of Headache and Pain
|
October 2, 2025
Application of machine learning in migraine classification: a call for study design standardization and global collaboration
Igor Petrušić, Roberta Messina, Lanfranco Pellesi, et al.
The Journal of Headache and Pain
|
December 24, 2025
Risk factors associated to disability in primary headaches: a systematic review to inform future iterations of the Global Burden of Disease Study
Alberto Raggi, Matteo Castaldo, Chia-Chun Chiang, et al.
Frontiers in Neurology
|
January 3, 2022
Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men
Raffaele Ornello, Carlo Baraldi, Simona Guerzoni, et al.
The Journal of Headache and Pain
|
March 20, 2022
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study
Raffaele Ornello, Carlo Baraldi, Simona Guerzoni, et al.
The Journal of Headache and Pain
|
November 1, 2024
Hallmarks of primary headache: part 1 - migraine
Alberto Raggi, Matilde Leonardi, Marco Arruda, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
The Journal of Headache and Pain
|
April 4, 2025
Correction: Combining treatments for migraine prophylaxis: the state‑of‑the‑art
Lanfranco Pellesi, David Garcia-Azorin, Eloisa Rubio-Beltrán, et al.
The Journal of Headache and Pain
|
October 9, 2023
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention - part 3: topiramate
Bianca Raffaelli, David García-Azorín, Deirdre M Boucherie, et al.
JAMA Network Open
|
June 17, 2025
Erenumab for Chronic Cluster Headache: A Randomized Clinical Trial
Jasper Mecklenburg, Charly Gaul, Mira Fitzek, et al.
The Journal of Headache and Pain
|
March 2, 2026
Hallmarks of headache disorders: part 5 - secondary headaches
David García-Azorín, Alba Perez-de-la-Parte, Claudio Tana, et al.
The Journal of Headache and Pain
|
October 12, 2022
European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
Simona Sacco, Christian Lampl, Faisal Mohammad Amin, et al.
The Journal of Headache and Pain
|
October 2, 2025
Application of machine learning in migraine classification: a call for study design standardization and global collaboration
Igor Petrušić, Roberta Messina, Lanfranco Pellesi, et al.
The Journal of Headache and Pain
|
December 24, 2025
Risk factors associated to disability in primary headaches: a systematic review to inform future iterations of the Global Burden of Disease Study
Alberto Raggi, Matteo Castaldo, Chia-Chun Chiang, et al.
Frontiers in Neurology
|
January 3, 2022
Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men
Raffaele Ornello, Carlo Baraldi, Simona Guerzoni, et al.
The Journal of Headache and Pain
|
March 20, 2022
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study
Raffaele Ornello, Carlo Baraldi, Simona Guerzoni, et al.
The Journal of Headache and Pain
|
November 1, 2024
Hallmarks of primary headache: part 1 - migraine
Alberto Raggi, Matilde Leonardi, Marco Arruda, et al.
Page
of 10